Lubiprostone Capsule
Product Images NDC 70710-1641

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 70710-1641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F06e99fa 9894 48ab 99d8 914987dbb73f 01)

Chemical structure of lubiprostone, showing its molecular arrangement with multiple rings, hydroxyl groups, fluorine atoms, and a carboxylic acid functional group.*

FDA Label Image

8 Mcg Label (F06e99fa 9894 48ab 99d8 914987dbb73f 02)

Lubiprostone Capsules 8 mcg oral capsules label from Zydus Pharmaceuticals USA Inc. The label indicates a package size of 60 capsules, with instructions not to break apart or chew the capsules. It includes storage instructions, child-resistant packaging notice, and distribution information for Zydus Lifesciences Ltd. and Zydus Pharmaceuticals USA Inc.*

FDA Label Image

24 Mcg Label (F06e99fa 9894 48ab 99d8 914987dbb73f 03)

Lubiprostone Capsules 24 mcg oral capsules packaging label by Zydus Pharmaceuticals USA Inc. The label states 60 capsules per container, with a note to swallow whole and not break apart or chew. It includes storage instructions, child-resistant packaging notice, and manufacturer and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.